Most Recent
Two GPS tracking patents at the heart of a David vs. Goliath battle between Domino's and a Sydney-based startup were foreshadowed by a patent owned by Uber, the pizza chain giant told a court Friday.
Law firm Corrs Chambers Westgarth is following in the footsteps of Squire Patton Boggs, with both now challenging a ruling that halted their shareholder class actions against logistics startup GetSwift.
Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, pharmaceutical giant Wyeth told a judge on day two of a six-week trial over its blockbuster antidepressant.
Pharmaceutical giant Wyeth's has launched an "ambush" at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.
A decade-long courtroom battle over a patent for Effexor-XR that delayed the release of cheap versions of the anti-depressant is at the centre of a trial starting Monday in Sydney pitting four generic drug makers against pharmaceutical giant Wyeth.
As Apple gears up to face off against the ACCC next month for allegedly misleading iPhone and iPad users about their rights to have faulty devices repaired free of charge, it has received a fresh warning that it may have violated consumer laws, this time in New Zealand, by setting expiry dates on consumer guarantees.
Generic drug giant Actavis Global has reached a settlement with AstraZeneca in a long-running patent dispute over blockbuster cholesterol medicine Crestor that wound its way to the High Court.
Three weeks after a court heard Bannister Law could be forced off a massive class action against Ford, Corrs Chambers Westgarth has joined the case to jointly act for the lead applicants.
A decision on the fate of three class actions against logistics software company GetSwift is set for Wednesday, and counsel behind the competing cases aren't the only lawyers waiting with baited breath.
Telecom giant Optus has come up short in a Federal Court challenge to trademark registration for health services company Optum, with a judge saying the two company's marks -- despite the difference of just one letter -- were distinct enough.